Quality
Contact Us
Feedback
Newsletter
Register for Alerts
 
 
Neiss Prescription Medicine Launches
 
   Pipeline - Prescription Medicine
 
Serial No Molecule Therapeutic Segment Approximate Expected Launch Date
1 Erythropoietin Nephrology October 2008
2 Filgrastim Oncology October 2008
       

 

Eye Drops to be launched by april 2010
 
Serial No Molecule Therapeutic Segment Approximate Expected Launch Date
1 Olopatadine 0.1 % Eye drops April 2010
2 Latanoprost 0.005%w/v Eye drops April 2010
3 Latanoprost 0.005% and Timolol 0.5% Eye drops April 2010
4 Brimonidine Tartrate 0.2% 0.5%, Eye drops April 2010
5 Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5% Eye drops April 2010
6 Bimatoprost+Timolol Maleate 300 micrograms/ml Eye drops April 2010
7 Dorzolamide Hydrochloride–Timolol Maleate Eye drops April 2010
8 Dorzolamide Hydrochloride Eye drops April 2010
9 Loteprednol etabonate ophthalmic suspension 0.2%

Eye drops April 2010
10 Flurbiprofen – Ophthalmic 0.03% Eye drops April 2010
11 Moxifloxacin 0.5% Eye drops April 2010

 

                                                                                                                                                                BACK
 
 
Sitemap | Privacy Policy | Accessibility | Terms and Conditions
Procurement | Credits | Oncology Injections | Dermatology | Qualitron | Xml Sitemap
© 2004 - 2008 Neiss Labs Pvt. Ltd. All rights reserved.